StageBio

StageBio is a leading provider of research, preclinical, and clinical histology, pathology, and specimen archiving services. Headquartered in Mount Jackson, Virginia, the company employs 133 people and generates $100 million in annual revenue. StageBio offers a comprehensive suite of services for the biopharmaceutical, medical device, and contract research industries. Their offerings include tissue analysis, efficacy determination for new compounds and devices, toxicological evaluation of products subject to regulatory approval, detailed pathology reporting for GLP studies, medical device pathology, immunohistochemistry, and neuropathology. The company distinguishes itself through its extensive experience, having been formed through the merger of several well-respected histology and histopathology service providers. StageBio also boasts a global reach with eight U.S. facilities and one facility in Germany, enabling them to serve customers worldwide. For more information about StageBio and their services, visit their website at stagebio.com.